The trademark application FyzaMab was filed by FYZANT PHARMA PTE. LTD., a corporation established under the laws of the Republic of Singapore (the "Applicant"). The application was published for oppositions on September 15, 2020, and it was registered by office on December 24, 2020 without any oppositions.
The application was filed in Finnish (English was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Biomedical research services
Research and development in the field of biotechnology